Showing posts with label rheumatid arthritis. Show all posts
Showing posts with label rheumatid arthritis. Show all posts
Monday, August 31, 2015

Chemical compound shows promise in treating rheumatoid arthritis

›
Montana State University researchers and their collaborators have published their findings about a chemical compound that shows ...
Monday, July 23, 2012

RA Study Misses Primary Endpoint (CH-4051)...

›
In continuation of my update on CH-4051 Chelsea Therapeutics International, Ltd. (Nasdaq:CHTP) announced that a preliminary analysis of...
Friday, June 1, 2012

FDA AAC recommends approval of Pfizer’s tofacitinib for RA

›
In continuation of my update on  Tofacitinib ... FDA AAC recommends approval of Pfizer’s tofacitinib for RA : Pfizer Inc. the Arthriti...
Thursday, March 22, 2012

Researchers unlock mystery of how an inflammatory molecule is produced in the body

›
Researchers unlock mystery of how an inflammatory molecule is produced in the body : Cedars-Sinai researchers have unlocked the mystery of h...
Tuesday, May 31, 2011

UCB,s new data for Cimzia® (certolizumab pegol) showed a rapid clinical response across a broad population of RA patients

›
UCB, announced data which showed that the addition of Cimzia ® ( certolizumab pegol ) to current therapy was associated with a rapid and ...
Friday, May 27, 2011

Gout drug success for Novartis

›
Canakinumab (trade name Ilaris , previously ACZ885) is a human monoclonal antibody targeted at interleukin-1 beta. It has no cross-reactivi...